ReproSource specializes in advanced diagnostic testing for reproductive health, offering unique solutions such as the Ovarian Assessment Report (OAR™) and the @Home Collection service for semen analysis. The OAR™ is a highly accurate blood test designed to estimate a woman's ovulatory egg supply, providing fertility specialists and OBGYNs with critical insights that surpass traditional hormone testing methods. Additionally, the @Home Collection service allows patients to collect semen samples in the comfort of their homes, utilizing proprietary media and shipping processes that preserve semen parameters for accurate analysis. This innovative approach addresses common patient concerns about privacy and convenience while ensuring reliable results.

The company is committed to empowering clinicians and researchers with state-of-the-art testing capabilities, which are essential for diagnosing fertility issues and planning for future pregnancies. ReproSource's extensive validation studies demonstrate the reliability of their at-home semen analysis, showing that key parameters like motility can be preserved for up to 26 hours after collection. This service is particularly beneficial for remote patients, those who prefer privacy, and clinics lacking on-site analysis capabilities. By providing high-quality diagnostic services and patient-friendly reports, ReproSource aims to enhance reproductive outcomes and support informed decision-making for patients and healthcare providers alike.

United States

ReproSource, a Quest Diagnostics company, provides clinicians & patients with the best in fertility testing & information. Our founders include internationally recognized fertility experts in the areas of diagnostic research, clinical laboratory medicine, and the practice of fertility medicine.

ReproSource

Company Details